Company Filing History:
Years Active: 1996-2003
Title: Hirohiko Hasegawa: Innovator in Cholesterol-Lowering Agents
Introduction
Hirohiko Hasegawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cholesterol-lowering agents. With a total of 3 patents to his name, Hasegawa's work has the potential to impact the treatment of hypercholesterolemia and related disorders.
Latest Patents
Hasegawa's latest patents include innovative compounds that serve as cholesterol-lowering agents. One of his notable inventions is related to hydrazones and analogs, which are useful as upregulators of LDL receptors. These compounds can be utilized in the treatment of hypercholesterolemia and associated conditions. Another significant patent involves LXR modulators, which provide compounds, compositions, and methods for modulating the effects of LXR in a cell. These compounds are particularly useful as diagnostic indicators of LXR function and as pharmacologically active agents in treating diseases related to cholesterol metabolism, such as atherosclerosis and hypercholesterolemia.
Career Highlights
Throughout his career, Hasegawa has worked with reputable companies, including Tularik Limited and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Hasegawa has collaborated with notable professionals in his field, including Julio Cesar Medina and Leping Li. These collaborations have likely enriched his research and development efforts.
Conclusion
Hirohiko Hasegawa is a distinguished inventor whose work in cholesterol-lowering agents showcases his commitment to advancing medical science. His patents reflect a deep understanding of cholesterol metabolism and its implications for health.